| mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
0.012 |
0.8 |
| mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.0091 |
0.8 |
| mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.0067 |
0.9 |
| mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-08 |
| mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.39 |
4e-08 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
9e-08 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-07 |
| mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-07 |